» Articles » PMID: 35163660

Conversion of Human Fibroblasts into Induced Neural Stem Cells by Small Molecules

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2022 Feb 15
PMID 35163660
Authors
Affiliations
Soon will be listed here.
Abstract

Induced neural stem cells (iNSCs) reprogrammed from somatic cells hold great potentials for drug discovery, disease modelling and the treatment of neurological diseases. Although studies have shown that human somatic cells can be converted into iNSCs by introducing transcription factors, these iNSCs are unlikely to be used for clinical application due to the safety concern of using exogenous genes and viral transduction vectors. Here, we report the successful conversion of human fibroblasts into iNSCs using a cocktail of small molecules. Furthermore, our results demonstrate that these human iNSCs (hiNSCs) have similar gene expression profiles to bona fide NSCs, can proliferate, and are capable of differentiating into glial cells and functional neurons. This study collectively describes a novel approach based on small molecules to produce hiNSCs from human fibroblasts, which may be useful for both research and therapeutic purposes.

Citing Articles

Strategies for modeling aging and age-related diseases.

Jothi D, Kulka L NPJ Aging. 2024; 10(1):32.

PMID: 38987252 PMC: 11237002. DOI: 10.1038/s41514-024-00161-5.

References
1.
Li W, Wei W, Zhu S, Zhu J, Shi Y, Lin T . Generation of rat and human induced pluripotent stem cells by combining genetic reprogramming and chemical inhibitors. Cell Stem Cell. 2008; 4(1):16-9. DOI: 10.1016/j.stem.2008.11.014. View

2.
Liu D, Rychkov G, Al-Hawwas M, Manaph N, Zhou F, Bobrovskaya L . Conversion of human urine-derived cells into neuron-like cells by small molecules. Mol Biol Rep. 2020; 47(4):2713-2722. DOI: 10.1007/s11033-020-05370-1. View

3.
Han Y, Lim Y, Duffieldl M, Li H, Liu J, Manaph N . Direct Reprogramming of Mouse Fibroblasts to Neural Stem Cells by Small Molecules. Stem Cells Int. 2016; 2016:4304916. PMC: 4695670. DOI: 10.1155/2016/4304916. View

4.
Yasuhara T, Kameda M, Sasaki T, Tajiri N, Date I . Cell Therapy for Parkinson's Disease. Cell Transplant. 2017; 26(9):1551-1559. PMC: 5680961. DOI: 10.1177/0963689717735411. View

5.
Bellin M, Marchetto M, Gage F, Mummery C . Induced pluripotent stem cells: the new patient?. Nat Rev Mol Cell Biol. 2012; 13(11):713-26. DOI: 10.1038/nrm3448. View